Respiratory Immunization: Unlocking Protection for Pregnant Women and Immunocompromised Individuals
A critical discussion on safeguarding vulnerable populations.
The National Foundation for Infectious Diseases (NFID) invites you to a thought-provoking session, delving into the vital topic of respiratory vaccinations for pregnant women and those with compromised immune systems. This event promises to shed light on the latest US guidelines for COVID-19, flu, RSV, and pneumococcal disease prevention, addressing the often-overlooked disparities in immunization coverage.
But here's where it gets controversial...
Led by NFID's Medical Director, Dr. Robert (Bob) H. Hopkins, Jr., the discussion will feature insights from Dr. Kevin Ault, Vice President of NFID and Professor of Obstetrics and Gynecology at Western Michigan University, and Dr. Camille N. Kotton, Clinical Director of Transplant and Immunocompromised Host Infectious Diseases at Massachusetts General Hospital. Together, they will navigate the complex landscape of respiratory immunization, offering strategies to bridge the gap in immunization rates.
And this is the part most people miss...
By the end of this session, you'll be equipped with the knowledge to:
- Discuss the latest evidence-based vaccine recommendations for COVID-19, influenza, RSV, and pneumococcal disease, tailored for pregnant women and immunocompromised individuals.
- Uncover the disparities in respiratory immunization rates among these vulnerable groups.
- Identify practical, effective strategies to boost immunization rates and protect these populations.
The best part? It's free!
Pre-registration is a must, and here's why: NFID, accredited by the Accreditation Council for Continuing Medical Education (ACCME), ensures that physicians receive up to 1.0 AMA PRA Category 1 Credit™ for their participation. So, don't miss out on this opportunity to enhance your understanding and contribute to the well-being of these special populations.
Join us, and let's spark a conversation that could save lives.
